Gail C Megason
Overview
Explore the profile of Gail C Megason including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cuvelier G, Ng B, Abdossamadi S, Nemecek E, Melton A, Kitko C, et al.
Blood Adv
. 2022 Oct;
7(14):3612-3623.
PMID: 36219586
The National Institutes of Health Consensus criteria for chronic graft-versus-host disease (cGVHD) diagnosis can be challenging to apply in children, making pediatric cGVHD diagnosis difficult. We aimed to identify diagnostic...
2.
Subburaj D, Ng B, Kariminia A, Abdossamadi S, Lauener M, Nemecek E, et al.
Blood
. 2021 Sep;
139(2):287-299.
PMID: 34534280
Chronic graft-versus-host disease (cGVHD) is the most common cause for non-relapse mortality postallogeneic hematopoietic stem cell transplant (HSCT). However, there are no well-defined biomarkers for cGVHD or late acute GVHD...
3.
Schultz K, Kariminia A, Ng B, Abdossamadi S, Lauener M, Nemecek E, et al.
Blood
. 2020 Feb;
135(15):1287-1298.
PMID: 32047896
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transplantation (HSCT) is complex. The Applied Biomarker in Late Effects of Childhood Cancer study (ABLE/PBMTC1202, NCT02067832) evaluated the...
4.
Cuvelier G, Nemecek E, Wahlstrom J, Kitko C, Lewis V, Schechter T, et al.
Blood
. 2019 May;
134(3):304-316.
PMID: 31043425
Chronic graft-versus-host disease (cGVHD) and late acute graft-versus-host disease (L-aGVHD) are understudied complications of allogeneic hematopoietic stem cell transplantation in children. The National Institutes of Health Consensus Criteria (NIH-CC) were...
5.
Whipple N, Marion L, Dansie D, Murina A, Megason G, Vijayakumar V, et al.
Pediatr Hematol Oncol
. 2018 Oct;
35(3):177-180.
PMID: 30346866
No abstract available.
6.
Newman L, Luter M, Davis D, Abdul-Rahman O, Johnson J, Megason G
J Pediatr Hematol Oncol
. 2017 Jul;
39(7):573-575.
PMID: 28697167
Congenital amegakaryocytic thrombocytopenia is a rare disorder causing thrombocytopenia that progresses to pancytopenia and bone marrow failure if untreated. It is caused by variants in the MPL gene which encodes...
7.
Shenoy S, Eapen M, Panepinto J, Logan B, Wu J, Abraham A, et al.
Blood
. 2016 Sep;
128(21):2561-2567.
PMID: 27625358
Children with sickle cell disease experience organ damage, impaired quality of life, and premature mortality. Allogeneic bone marrow transplant from an HLA-matched sibling can halt disease progression but is limited...
8.
Chinchar E, Makey K, Gibson J, Chen F, Cole S, Megason G, et al.
Vasc Cell
. 2014 Jun;
6:12.
PMID: 24914410
The majority of triple-negative breast cancers (TNBCs) are basal-like breast cancers. However there is no reported study on anti-tumor effects of sunitinib in xenografts of basal-like TNBC (MDA-MB-468) cells. In...
9.
Ku E, Thomas M, Ho C, Whipple N, Abdul-Rahman O, Megason G, et al.
Pediatr Rev
. 2014 Mar;
35(3):129-35.
PMID: 24585816
No abstract available.
10.
Majumdar S, Friedrich C, Koch C, Megason G, Fratkin J, Moll G
Pediatr Blood Cancer
. 2009 Nov;
54(3):473-5.
PMID: 19927285
Pheochromocytoma and paraganglioma (PGL) are rare neuroendocrine tumors in children. Apparently sporadic cases of PGL may harbor germline mutations in the succinate dehydrogenase (SDHx) gene. SDHB mutations are associated with...